» Articles » PMID: 26858903

Cryopreservation of Adipose-Derived Mesenchymal Stem Cells

Overview
Journal Cell Med
Publisher Sage Publications
Date 2016 Feb 10
PMID 26858903
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) have the potential to differentiate into cells of mesodermal origin such as osteoblasts, adipocytes, myocytes, and chondrocytes. They possess an immunosuppressive effect, which makes them a viable cell population for the cell-based therapy of treatment-resistant immune diseases. Adipose-derived mesenchymal stem cells (ASCs) have been demonstrated to have the ability to acquire the properties of subcutaneous adipose tissue particularly easily, and cryopreservation is currently performed as a routine method for preserving ASCs to safely acquire large numbers of cells. However, many studies have reported that cellular activity after freezing and thawing may be affected by the solutions used for cryopreservation. Dimethyl sulfoxide (DMSO) is commonly used as a cryopreservation medium as it diffuses into the cell through the plasma membrane and protects the cells from the damage caused by freezing. As substitutes for DMSO or animal-derived serum, cell banker series, polyvinylpyrrolidone (PVP), sericin and maltose, and methyl cellulose (MC) have been investigated for their clinical applications. It is critical to develop a reliable cell cryopreservation protocol for regenerative medicine using MSCs.

Citing Articles

Distinct subpopulations of human subcutaneous adipose tissue precursor cells revealed by single-cell RNA sequencing.

Divoux A, Whytock K, Halasz L, Hopf M, Sparks L, Osborne T Am J Physiol Cell Physiol. 2024; 326(4):C1248-C1261.

PMID: 38581663 PMC: 11193533. DOI: 10.1152/ajpcell.00726.2023.


Transplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements.

Tajali R, Eidi A, Tafti H, Pazouki A, Kamarul T, Sharifi A J Diabetes Metab Disord. 2023; 22(2):1039-1052.

PMID: 37975135 PMC: 10638327. DOI: 10.1007/s40200-023-01280-8.


Factors Defining Human Adipose Stem/Stromal Cell Immunomodulation in Vitro.

Mahmoud M, Abdel-Rasheed M, Galal E, R El-Awady R Stem Cell Rev Rep. 2023; 20(1):175-205.

PMID: 37962697 PMC: 10799834. DOI: 10.1007/s12015-023-10654-7.


SVF-GEL Cryopreserved for Different Times Exhibits Varied Preservation and Regeneration Potential After Transplantation in a Mouse Model.

Tao Y, Zhao Z, Xiang X, Liang Z, Zhao Y Aesthetic Plast Surg. 2022; 47(2):842-851.

PMID: 36074301 PMC: 10070215. DOI: 10.1007/s00266-022-03065-5.


Biomaterials directed activation of a cryostable therapeutic secretome in induced pluripotent stem cell derived mesenchymal stromal cells.

Romanazzo S, Kopecky C, Jiang S, Doshi R, Mukund V, Srivastava P J Tissue Eng Regen Med. 2022; 16(11):1008-1018.

PMID: 36017672 PMC: 9804847. DOI: 10.1002/term.3347.


References
1.
Hass R, Kasper C, Bohm S, Jacobs R . Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011; 9:12. PMC: 3117820. DOI: 10.1186/1478-811X-9-12. View

2.
Minonzio G, Corazza M, Mariotta L, Gola M, Zanzi M, Gandolfi E . Frozen adipose-derived mesenchymal stem cells maintain high capability to grow and differentiate. Cryobiology. 2014; 69(2):211-6. DOI: 10.1016/j.cryobiol.2014.07.005. View

3.
Oishi K, Noguchi H, Yukawa H, Miyazaki T, Kato R, Kitagawa Y . Cryopreservation of mouse adipose tissue-derived stem/progenitor cells. Cell Transplant. 2008; 17(1-2):35-41. DOI: 10.3727/000000008783906937. View

4.
Ohgushi H, Caplan A . Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res. 1999; 48(6):913-27. DOI: 10.1002/(sici)1097-4636(1999)48:6<913::aid-jbm22>3.0.co;2-0. View

5.
Meryman H . Cryopreservation of living cells: principles and practice. Transfusion. 2007; 47(5):935-45. DOI: 10.1111/j.1537-2995.2007.01212.x. View